Biblio
Generation of integration-free human induced pluripotent stem cells from a patient with sporadic Parkinson's disease. Stem Cell Res. 2024;77:103416.
. Generation of integration-free human iPSC line LCPHi001-A from a Parkinson's disease patient carrying the RecNciI mutation in GBA gene. Stem Cell Res. 2021;56:102514.
Generation of integration-free induced pluripotent stem cell lines from four pediatric ADHD patients. Stem Cell Res. 2021;53:102268.
. Generation of integration-free induced pluripotent stem cell line (KSCBi012-A) from urinary epithelial cells of a healthy male individual. Stem Cell Res. 2022;63:102841.
. Generation of integration-free induced pluripotent stem cells from a patient with spina bifida. Stem Cell Res. 2018;31:27-30.
. Generation of integration-free induced pluripotent stem cells from blood-derived cells isolated from patient with severe haemophilia A. Haemophilia. 2019.
. Generation of integration-free induced pluripotent stem cells from healthy individuals. Stem Cell Res. 2021;53:102269.
. Generation of integration-free iPS cell lines from three sickle cell disease patients from the state of Bahia, Brazil. Stem Cell Res. 2018;33:10-14.
Generation of iPS cell line (ICGi040-A) from skin fibroblasts of a patient with ring small supernumerary marker chromosome 4. Stem Cell Res. 2022;61:102740.
Generation of iPS Cells from Human Hair Follice Dermal Papilla Cells. Acta Naturae. 2014;6(1):45-53.
Generation of iPSC from fetal fibroblast cells obtained from an abortus with type-I tri-allelic variants. Stem Cell Res. 2020;48:101963.
. Generation of iPSC from peripheral blood mononuclear cells obtained from a patient with TSC2-PKD1 contiguous gene deletion syndrome. Stem Cell Res. 2021;51:102181.
. Generation of iPSC line (FAMRCi009-A) from patient with familial progressive cardiac conduction disorder carrying genetic variant FLNC p.Val2264Met. Stem Cell Res. 2021;59:102640.
. Generation of iPSC line FAMRCi010-A from patient with restrictive cardiomyopathy carrying genetic variant FLNC p.Gly2011Arg. Stem Cell Res. 2021;59:102639.
. Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control. Stem Cell Res. 2021;52:102245.
Generation of iPSC line from urine cells of hemophilia A with F8 (p. R814X) mutation. Stem Cell Res. 2022;60:102682.
. Generation of iPSC line (GIBHi001-A) from a patient with autism spectrum disorder. Stem Cell Res. 2019;40:101571.
Generation of iPSC line (GLNNFi001-A) from peripheral blood mononuclear cells of a patient with macular corneal dystrophy. Stem Cell Res. 2022;62:102789.
. Generation of iPSC line HEL24.3 from human neonatal foreskin fibroblasts. Stem Cell Res. 2015.
. Generation of iPSC line ICGi024-A from human skin fibroblasts of a patient with ring chromosome 18. Stem Cell Res. 2020;49:102076.
Generation of iPSC line NCHi012-A from a patient with Alagille syndrome and heterozygous pathogenic variant in the JAG1 gene. Stem Cell Res. 2023;71:103177.
. Generation of iPSC line (USTCi001-A) from human skin fibroblasts of a patient with epilepsy. Stem Cell Res. 2020;45:101785.
Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations. Stem Cell Res. 2022;64:102917.
. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults. Stem Cell Res. 2018;34:101380.
.